Why the study?
The study was conducted to identify sub-clinical cardiac abnormalities by echocardiography in patients with CKD stages 3 and 4 and to investigate underlying mechanisms.
Does moderate chronic kidney disease without clinical heart disease associate with reduced coronary flow velocity reserve and sub-clinical cardiac abnormalities compared to healthy controls?
Does moderate chronic kidney disease without clinical heart disease associate with reduced coronary flow velocity reserve and sub-clinical cardiac abnormalities compared to healthy controls?
Patients with moderate CKD without clinical heart disease exhibit early subclinical left ventricular diastolic abnormalities and a high prevalence of coronary microvascular dysfunction, which may contribute to the development of heart failure.
Associates moderate CKD with prevalent CMD; leaves open whether this drives future heart failure.
AIMS: The overall aim was to identify sub-clinical cardiac abnormalities by echocardiography in patients with chronic kidney disease (CKD) stages 3 and 4 and to investigate underlying mechanisms. METHODS AND RESULTS: Ninety-one patients with CKD stages 3 and 4, without a diagnosis of heart disease, and 41 healthy matched controls were included in this cross-sectional study. Cardiac morphology and function were analysed with Doppler echocardiography and coronary flow velocity reserve (CFVR) in response to adenosine was measured in the left anterior descendent artery to detect coronary microvascular dysfunction (CMD). All study subjects had a left ventricular (LV) ejection fraction > 50%. Patients with CKD showed statistically significant increases in left atrial volume index and transmitral and pulmonary vein flow velocities during atrial contraction and prolonged LV isovolumetric relaxation time. Patients with CKD had significantly reduced CFVR vs. controls (2.74 ± 0.86 vs. 3.40 ± 0.89, P < 0.001), and 43% of patients were classified as having CMD compared with 9% of controls (P = 0.001). CONCLUSIONS: Patients with CKD stages 3 and 4, without a diagnosis of heart disease, showed early abnormalities in LV diastolic function that did not fulfil the criteria for LV dysfunction according to current guidelines. A large proportion of CKD patients had CMD, suggesting that microvascular abnormalities may have a pathogenic role in the development of heart failure in this patient group.
No takes yet. Share an insight, caveat, or question.
Kashioulis et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: